|
DE2611690A1
(de)
*
|
1976-03-19 |
1977-09-22 |
Goedecke Ag |
Cyclische sulfonyloxyimide
|
|
JPS5776189U
(es)
*
|
1980-10-28 |
1982-05-11 |
|
|
|
JPS5847580U
(ja)
*
|
1981-09-28 |
1983-03-30 |
本田技研工業株式会社 |
車両用荷物箱の取付構造
|
|
JPS6152583U
(es)
*
|
1984-09-11 |
1986-04-09 |
|
|
|
JPS61139881U
(es)
*
|
1985-02-21 |
1986-08-29 |
|
|
|
US4876279A
(en)
*
|
1986-05-05 |
1989-10-24 |
Merck & Co., Inc. |
Antihypercholesterolemic compounds
|
|
US4960931A
(en)
*
|
1988-05-02 |
1990-10-02 |
Warner-Lambert Company |
Gabapentin mohohydrate and a process for producing the same
|
|
US4894476A
(en)
*
|
1988-05-02 |
1990-01-16 |
Warner-Lambert Company |
Gabapentin monohydrate and a process for producing the same
|
|
YU162789A
(en)
*
|
1988-09-01 |
1990-12-31 |
Lonza Ag |
2-aza-4-(alcoxycarbonyl) spiro/4,5/decan-3-ones
|
|
MY106864A
(en)
*
|
1989-08-25 |
1995-08-30 |
Warner Lambert Co |
Improved process for cyclic amino acid anticonvulsant compounds.
|
|
US5319135A
(en)
*
|
1989-08-25 |
1994-06-07 |
Warner-Lambert Company |
Process for cyclic amino acid anticonvulsant compounds
|
|
DE3928184A1
(de)
*
|
1989-08-25 |
1991-02-28 |
Goedecke Ag |
Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte
|
|
US5132451A
(en)
*
|
1989-08-25 |
1992-07-21 |
Warner-Lambert Company |
Process for cyclic amino acid anticonvulsant compounds
|
|
DE3928182A1
(de)
*
|
1989-08-25 |
1991-02-28 |
Goedecke Ag |
Verfahren zur herstellung von gabapentin
|
|
DE3928183A1
(de)
*
|
1989-08-25 |
1991-02-28 |
Goedecke Ag |
Lactamfreie cyclische aminosaeuren
|
|
US5136091A
(en)
*
|
1989-11-16 |
1992-08-04 |
Lonza Ltd. |
Process for the production of 1-(aminomethyl) cyclohexane acetic acid
|
|
GB8925933D0
(en)
*
|
1989-11-16 |
1990-01-04 |
Pfizer Ltd |
Glutaric acid derivatives and preparation thereof
|
|
US5260467A
(en)
*
|
1989-11-16 |
1993-11-09 |
Pfizer Inc. |
Glutaric acid derivatives and preparation thereof
|
|
FI905584A
(fi)
*
|
1989-11-16 |
1991-05-17 |
Lonza Ag |
Foerfarande foer framstaellning av 1-(aminometyl)cyklohexanaettikssyra.
|
|
US5157138A
(en)
*
|
1989-11-16 |
1992-10-20 |
Pfizer, Inc. |
Glutaric acid derivatives and preparation thereof
|
|
US5149870A
(en)
*
|
1989-11-16 |
1992-09-22 |
Lonza Ltd. |
Process for the production of 1-(aminomethyl)cyclohexane acetic acid
|
|
US5084479A
(en)
*
|
1990-01-02 |
1992-01-28 |
Warner-Lambert Company |
Novel methods for treating neurodegenerative diseases
|
|
US5025035A
(en)
*
|
1990-10-12 |
1991-06-18 |
Warner-Lambert Company |
Method of treating depression
|
|
US5792796A
(en)
*
|
1994-07-27 |
1998-08-11 |
Warner-Lambert Company |
Methods for treating anxiety and panic
|
|
US5510381A
(en)
*
|
1995-05-15 |
1996-04-23 |
Warner-Lambert Company |
Method of treatment of mania and bipolar disorder
|
|
PT888325E
(pt)
*
|
1996-02-07 |
2002-10-31 |
Warner Lambert Co |
Novos amino acidos ciclicos como agentes farmaceuiticos
|
|
DK0888286T3
(da)
*
|
1996-03-14 |
2002-02-18 |
Warner Lambert Co |
Nye substituerede cykliske aminosyrer som farmaceutiske midler
|
|
NZ331142A
(en)
*
|
1996-03-14 |
2001-04-27 |
Warner Lambert Co |
Bridged cyclic amino acids as pharmaceutical agents
|
|
BR9710536A
(pt)
|
1996-07-24 |
1999-08-17 |
Warner Lambert Co |
Isobutilgaba e seus derivados para o tratamento da dor
|
|
US6153650A
(en)
*
|
1996-10-23 |
2000-11-28 |
Warner-Lambert Company |
Substituted gamma aminobutyric acids as pharmaceutical agents
|
|
US6255526B1
(en)
|
1996-12-24 |
2001-07-03 |
Teva Pharmaceutical Industries Ltd. |
Preparation of gabapentin
|
|
IL119890A
(en)
*
|
1996-12-24 |
2002-03-10 |
Teva Pharma |
Gabapentin form iii and preparation of gabapentin form ii
|
|
HRP980342A2
(en)
*
|
1997-06-25 |
1999-02-28 |
Warner Lambert Co |
Anti-inflammatory method
|
|
US6329429B1
(en)
|
1997-06-25 |
2001-12-11 |
Warner-Lambert Company |
Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseases
|
|
US6194459B1
(en)
|
1997-08-19 |
2001-02-27 |
Warner-Lambert Company |
Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotors stimulants
|
|
ES2253825T3
(es)
*
|
1997-09-08 |
2006-06-01 |
Warner-Lambert Company Llc |
Composiciones analgesicas que comprenden compuestos antiepilepticos y procedimientos para usar las mismas.
|
|
AU9318398A
(en)
|
1997-10-07 |
1999-04-27 |
Warner-Lambert Company |
Process for preparing a cyclic amino acid anticonvulsant compound
|
|
CN1303059C
(zh)
*
|
1997-10-27 |
2007-03-07 |
沃尼尔·朗伯公司 |
作为药物的环状氨基酸及其衍生物
|
|
US6984659B2
(en)
*
|
1997-11-18 |
2006-01-10 |
Klinikum Der Albert-Ludwigs Universitaet |
2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level
|
|
DK1045839T3
(da)
|
1997-12-16 |
2004-07-05 |
Warner Lambert Co |
Hidtil ukendte aminer som farmaceutiske midler
|
|
TR200001795T2
(tr)
*
|
1997-12-16 |
2000-11-21 |
Warner-Lambert Company |
1-İkameli-1-Aminometil-sikloalkan türevleri (=Gabapentin analogları), bunların hazırlanması ve nörolojik bozuklukların tedavisinde kullanımı.
|
|
TR200001800T2
(tr)
|
1997-12-16 |
2001-03-21 |
Warner-Lambert Company |
-4(3)-İkameli -4(3)- aminometil-(tio) piran veya- piperidin türevleri (=Gabapentin analogları), hazırlanmaları ve nörolojik hastalıkların tedavisinde kullanımları
|
|
EP1047414A1
(en)
*
|
1998-01-23 |
2000-11-02 |
Warner-Lambert Company |
Gabapentin and its derivatives for the treatment of muscular and skeletal pain
|
|
EP0974351A3
(en)
*
|
1998-04-24 |
2000-12-13 |
Jouveinal |
Medicament for preventing and treating gastrointestinal damage
|
|
CN100337687C
(zh)
*
|
1998-05-15 |
2007-09-19 |
沃尼尔·朗伯公司 |
含有γ－氨基丁酸衍生物的固体组合物及其制备方法
|
|
SI1077692T1
(en)
|
1998-05-15 |
2004-10-31 |
Warner-Lambert Company Llc |
Amino acid stabilized gabapentin and pregabalin preparations and process for preparing the same
|
|
ES2137137B1
(es)
*
|
1998-05-25 |
2000-08-16 |
Medichem Sa |
Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica.
|
|
EP1082306A1
(en)
|
1998-05-26 |
2001-03-14 |
Warner-Lambert Company |
Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
|
|
ITMI981535A1
(it)
*
|
1998-07-03 |
2000-01-03 |
Zambon Spa |
Processo per la preparazione di gabapentina
|
|
US20030045500A1
(en)
*
|
1998-07-09 |
2003-03-06 |
Leslie Magnus |
Pharmaceutical composition containing GABA analogs and an antiviral agent to treat shingles
|
|
FR2781793B1
(fr)
|
1998-08-03 |
2001-07-20 |
Prographarm Lab |
Procede de fabrication de granules de gabapentine enrobes
|
|
HU225502B1
(en)
*
|
1998-12-29 |
2007-01-29 |
Richter Gedeon Vegyeszet |
Process for producing 1-(amino-metyl)-cyclohexene-acetic-acid and intermediates
|
|
IT1311984B1
(it)
|
1999-03-26 |
2002-03-22 |
Bioindustria Lab Italiano Medi |
Procedimento per la preparzione di gabapentin.
|
|
JP2002541215A
(ja)
*
|
1999-04-09 |
2002-12-03 |
ユーロ−セルティック エス． ア． |
ナトリウムチャネル遮断薬組成物およびその使用
|
|
DE60017730T2
(de)
*
|
1999-05-28 |
2005-06-23 |
Warner-Lambert Co. Llc |
3-heteroarylalkyl-substituierte gaba-analoga
|
|
US6710190B1
(en)
|
1999-05-28 |
2004-03-23 |
Warner-Lambert Company |
3-heteroarylalkyl substituted gaba analogs
|
|
GEP20074142B
(en)
*
|
1999-06-10 |
2007-07-10 |
Warner Lambert Co |
Mono- and Disubstituted 3-Propyl Gamma-Aminobutyric Acids
|
|
US7164034B2
(en)
*
|
1999-06-10 |
2007-01-16 |
Pfizer Inc. |
Alpha2delta ligands for fibromyalgia and other disorders
|
|
US20080207755A1
(en)
*
|
2000-05-31 |
2008-08-28 |
Pfizer Inc |
Alpha 2 Delta Ligands For Fibromyalgia and Other Disorders
|
|
US6294198B1
(en)
*
|
1999-08-24 |
2001-09-25 |
Purepac Pharmaceutical Co. |
Pharmaceutical tablet formulation containing gabapentin with improved physical and chemical characteristics and method of making the same
|
|
HN2000000224A
(es)
*
|
1999-10-20 |
2001-04-11 |
Warner Lambert Co |
Aminoacidos biciclicos como agentes farmaceuticos
|
|
GB2362646A
(en)
*
|
2000-05-26 |
2001-11-28 |
Warner Lambert Co |
Cyclic amino acid derivatives useful as pharmaceutical agents
|
|
EP1384473A1
(en)
*
|
2000-06-16 |
2004-01-28 |
Teva Pharmaceutical Industries Ltd. |
Stable gabapentin containing more than 20 ppm of chlorine ion
|
|
HUP0301919A3
(en)
*
|
2000-06-16 |
2006-01-30 |
Teva Pharma |
Stable gabapentin having ph within a controlled range
|
|
PT1289364E
(pt)
|
2000-06-16 |
2004-04-30 |
Teva Pharma |
Gabapentina estavel contendo mais do que 20 ppm de iao cloreto
|
|
ATE390133T1
(de)
*
|
2000-06-26 |
2008-04-15 |
Warner Lambert Co |
Gabapentinanaloga für schlafstörungen
|
|
GB2364049A
(en)
*
|
2000-06-28 |
2002-01-16 |
Warner Lambert Co |
Cyclic ketones and their use in the synthesis of amino acids
|
|
DK1317426T3
(da)
*
|
2000-09-14 |
2006-01-09 |
Gruenenthal Gmbh |
Betal-thio-aminosyrer
|
|
US6992076B2
(en)
*
|
2000-10-06 |
2006-01-31 |
Xenoport, Inc. |
Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
|
|
AU2002230398A1
(en)
*
|
2000-10-06 |
2002-04-29 |
Xenoport, Inc. |
Bile-acid conjugates for providing sustained systemic concentrations of drugs
|
|
US6620829B2
(en)
*
|
2000-10-17 |
2003-09-16 |
Warner-Lambert Company |
Method of treating noninflammatory cartilage damage
|
|
IT1319234B1
(it)
*
|
2000-10-23 |
2003-09-26 |
Zambon Spa |
Processo di preparazione di gabapentina.
|
|
GB2368579A
(en)
*
|
2000-10-31 |
2002-05-08 |
Parke Davis & Co Ltd |
Azole pharmaceutical agents
|
|
IL155733A0
(en)
*
|
2000-11-02 |
2003-11-23 |
Teva Pharma |
Improved process for production of gabapentin intermediate
|
|
EP1337271B1
(en)
*
|
2000-11-30 |
2004-11-03 |
Pfizer Products Inc. |
Combination of gaba agonists and sorbitol dehydrogenase inhibitors
|
|
EE200300249A
(et)
*
|
2000-11-30 |
2003-10-15 |
Pfizer Products Inc. |
GABA agonistide ja aldoosreduktaasi inhibiitoritekombinatsioon
|
|
IT1319674B1
(it)
*
|
2000-12-01 |
2003-10-23 |
Erregierre Spa |
Processo per la preparazione dell'acido1-(aminometil)cicloesanacetico.
|
|
US20040063994A1
(en)
*
|
2001-03-16 |
2004-04-01 |
Paolo Rossi |
Process for the preparation of cyclic amino acids
|
|
ITMI20011132A1
(it)
|
2001-05-29 |
2002-11-29 |
Procos Spa |
Procedimento per la preparazione dell'acido 1-amminometil-1-cicloesanacetico
|
|
US7232924B2
(en)
*
|
2001-06-11 |
2007-06-19 |
Xenoport, Inc. |
Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
|
|
US7186855B2
(en)
*
|
2001-06-11 |
2007-03-06 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
WO2002100344A2
(en)
*
|
2001-06-11 |
2002-12-19 |
Xenoport, Inc. |
Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
|
|
US8048917B2
(en)
|
2005-04-06 |
2011-11-01 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
ES2296956T5
(es)
*
|
2001-06-11 |
2011-07-12 |
Xenoport, Inc. |
Profármacos de análogos de gaba, composiciones y sus usos.
|
|
US6818787B2
(en)
|
2001-06-11 |
2004-11-16 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
IL144066A0
(en)
*
|
2001-06-28 |
2002-04-21 |
Bromine Compounds Ltd |
Process for the preparation of 1,1-cyclohexane diacetic monoamide
|
|
ITMI20011772A1
(it)
|
2001-08-10 |
2003-02-10 |
A M S A Anonima Materie Sint E |
Processo per la preparazione della 2,5-bis-(2,2,2-trifluoroetossi)-n-(2-piperidilmetil)-benzamide(flecainide)
|
|
NZ531586A
(en)
*
|
2001-09-03 |
2005-09-30 |
Newron Pharm Spa |
Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use
|
|
US6800782B2
(en)
*
|
2001-10-09 |
2004-10-05 |
Warner-Lambert Co. |
Anhydrous crystalline forms of gabapentin
|
|
TWI312285B
(en)
|
2001-10-25 |
2009-07-21 |
Depomed Inc |
Methods of treatment using a gastric retained gabapentin dosage
|
|
US7612112B2
(en)
|
2001-10-25 |
2009-11-03 |
Depomed, Inc. |
Methods of treatment using a gastric retained gabapentin dosage
|
|
US20060159743A1
(en)
*
|
2001-10-25 |
2006-07-20 |
Depomed, Inc. |
Methods of treating non-nociceptive pain states with gastric retentive gabapentin
|
|
US20070184104A1
(en)
*
|
2001-10-25 |
2007-08-09 |
Depomed, Inc. |
Gastric retentive gabapentin dosage forms and methods for using same
|
|
ITMI20012750A1
(it)
|
2001-12-21 |
2003-06-21 |
Procos Spa |
Processo per la produzione dell'acido 1-(amminometil)-cicloesil-acetico in forma pura
|
|
US20030119908A1
(en)
*
|
2001-12-21 |
2003-06-26 |
Zambon Group S.P.A. |
Stable gabapentin compositions
|
|
KR20040081478A
(ko)
*
|
2002-01-31 |
2004-09-21 |
워너-램버트 캄파니 엘엘씨 |
이명을 치료하기 위한 알파 2 델타 리간드
|
|
US6682759B2
(en)
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
|
WO2003077902A1
(en)
|
2002-02-19 |
2003-09-25 |
Xenoport, Inc. |
Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
|
|
AU2003222033A1
(en)
*
|
2002-03-20 |
2003-10-08 |
Xenoport |
Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof
|
|
WO2003089403A1
(en)
*
|
2002-04-16 |
2003-10-30 |
Taro Pharmaceutical Industries Ltd. |
Process for preparing gabapentin
|
|
US20050153928A1
(en)
*
|
2002-05-07 |
2005-07-14 |
Holick Michael F. |
Conjugates comprising a central nervous system-active drug linked to glucuronic acid or glucosamine through an amide bond and uses thereof
|
|
WO2003099338A2
(en)
*
|
2002-05-17 |
2003-12-04 |
Xenoport, Inc. |
Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
|
|
WO2004002462A2
(en)
*
|
2002-06-27 |
2004-01-08 |
Warner-Lambert Company Llc |
Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder
|
|
CA2395931A1
(en)
*
|
2002-08-07 |
2004-02-07 |
Bernard Charles Sherman |
Solid compositions comprising gabapentin having improved stability
|
|
US7053122B2
(en)
*
|
2002-08-09 |
2006-05-30 |
Pfizer Inc |
Therapeutic use of aryl amino acid derivatives
|
|
US20040092591A1
(en)
*
|
2002-08-15 |
2004-05-13 |
Blakemore David Clive |
Therapeutic use of fused bicyclic or tricyclic amino acids
|
|
US20040092522A1
(en)
*
|
2002-08-15 |
2004-05-13 |
Field Mark John |
Synergistic combinations
|
|
US7419981B2
(en)
*
|
2002-08-15 |
2008-09-02 |
Pfizer Inc. |
Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
|
|
US20040092498A1
(en)
*
|
2002-08-16 |
2004-05-13 |
David Blakemore |
Substituted glycine derivatives for use as medicaments
|
|
ITMI20022071A1
(it)
*
|
2002-10-01 |
2004-04-02 |
Erregierre Spa |
Processo di sintesi dell'acido 1-(aminometil)cicloesanacetico cloridato.
|
|
US7659305B2
(en)
*
|
2002-10-31 |
2010-02-09 |
Pfizer Inc. |
Therapeutic proline derivatives
|
|
DE60230552D1
(de)
*
|
2002-11-18 |
2009-02-05 |
Nicholas Piramal India Ltd |
Verbessertes verfahren zur herstellung von gabapentin
|
|
US7632953B2
(en)
*
|
2002-11-20 |
2009-12-15 |
Hikal Limited |
Process for the preparation of gabalactam
|
|
WO2004052360A1
(en)
*
|
2002-12-11 |
2004-06-24 |
Xenoport, Inc. |
Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof
|
|
WO2004053192A1
(en)
*
|
2002-12-11 |
2004-06-24 |
Xenoport, Inc. |
Orally administered dosage forms of fused gaba analog prodrugs having reduced toxicity
|
|
EP1572184A1
(en)
*
|
2002-12-13 |
2005-09-14 |
Warner-Lambert Company |
Gabapentin analogues for fibromyalgia and other related disorders
|
|
JP2006513257A
(ja)
*
|
2002-12-13 |
2006-04-20 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
線維筋痛症および他の障害を処置するためのプレガバリン誘導体
|
|
KR20050085563A
(ko)
|
2002-12-13 |
2005-08-29 |
워너-램버트 캄파니 엘엘씨 |
하부요로증상을 치료하기 위한 알파-2-델타 리간드
|
|
US20040180958A1
(en)
*
|
2002-12-13 |
2004-09-16 |
Taylor Charles Price |
Method of treatment
|
|
KR100845932B1
(ko)
*
|
2002-12-13 |
2008-07-11 |
워너-램버트 캄파니 엘엘씨 |
섬유근육통 및 기타 관련 질환의 치료를 위한 프레가발린및 그의 유도체
|
|
CA2451267A1
(en)
*
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
|
GB0301143D0
(en)
*
|
2003-01-17 |
2003-02-19 |
Amedis Pharm Ltd |
Compounds and their use
|
|
BRPI0406811A
(pt)
*
|
2003-01-22 |
2005-12-27 |
Warner Lambert Co |
Derivados de ciclopropil ß-aminoácido
|
|
MXPA05009504A
(es)
*
|
2003-03-07 |
2005-10-18 |
Warner Lambert Co |
Derivados de (-aminoacidos sustituidos con tetrazol y oxadiazolona.
|
|
EP1622603A4
(en)
*
|
2003-03-25 |
2010-03-24 |
Kiel Lab Inc |
GABAPENTINIC PHENOLIC ACID SALTS IN SOLID DOSAGE FORMS AND METHODS OF USE
|
|
WO2004093867A2
(en)
*
|
2003-03-25 |
2004-11-04 |
Kiel Laboratories, Inc. |
Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use
|
|
WO2004093866A1
(en)
*
|
2003-03-25 |
2004-11-04 |
Kiel Laboratories, Inc. |
Process for preparing phenolic acid salts of gabapentin
|
|
EP1608357A4
(en)
*
|
2003-03-31 |
2008-03-26 |
Xenoport Inc |
TREATMENT OR PREVENTION OF HITZEWALLUNGEN USING PRODRUGS OF GABA ANALOGUE
|
|
WO2004091278A2
(en)
*
|
2003-04-11 |
2004-10-28 |
Transform Pharmaceuticals, Inc. |
Gabapentin compositions
|
|
ITMI20030825A1
(it)
*
|
2003-04-18 |
2004-10-19 |
Farchemia Srl |
Procedimento per la preparazione di gabapentin esente da
|
|
EP1615875A2
(en)
*
|
2003-04-21 |
2006-01-18 |
Matrix Laboratories Limited |
Process for the preparation of gabapentin form-ii
|
|
BRPI0410271A
(pt)
*
|
2003-05-16 |
2006-05-16 |
Pfizer Prod Inc |
combinações terapêuticas de antipsicóticos atìpicos com moduladores de gaba, anticonvulsivantes ou benzodiazepinas
|
|
WO2004111256A1
(en)
*
|
2003-06-19 |
2004-12-23 |
Pfizer Products Inc. |
Biocatalytic preparation of 1-cyanocyclohexaneacetic acid
|
|
US7169812B2
(en)
*
|
2003-07-01 |
2007-01-30 |
Medtronic, Inc. |
Process for producing injectable gabapentin compositions
|
|
WO2005002585A1
(en)
*
|
2003-07-02 |
2005-01-13 |
Warner-Lambert Company Llc |
Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
|
|
US20050013863A1
(en)
|
2003-07-18 |
2005-01-20 |
Depomed, Inc., A Corporation Of The State Of California |
Dual drug dosage forms with improved separation of drugs
|
|
WO2005046566A2
(en)
*
|
2003-08-04 |
2005-05-26 |
Sun Pharmaceutical Industries Limited |
Stable gabapentin containing composition
|
|
US20050043407A1
(en)
*
|
2003-08-22 |
2005-02-24 |
Pfizer Inc |
Pharmaceutical composition for the prevention and treatment of addiction in a mammal
|
|
NZ545884A
(en)
*
|
2003-09-11 |
2010-01-29 |
Xenoport Inc |
Treating and/or preventing urinary incontinence using prodrugs of GABA analogs
|
|
KR20060087560A
(ko)
*
|
2003-09-12 |
2006-08-02 |
워너-램버트 캄파니 엘엘씨 |
알파-2-델타 리간드 및 ｓｓｒｉ 및/또는 ｓｎｒｉ를포함하는 우울증 및 불안 장애 치료용 조합물
|
|
BRPI0414343A
(pt)
*
|
2003-09-12 |
2006-11-07 |
Pfizer |
combinações que compreendem ligantes de alfa-2-delta e inibidores da reabsorção de serotonina/noradrenalina
|
|
NZ545989A
(en)
*
|
2003-09-17 |
2009-10-30 |
Xenoport Inc |
Treating or preventing restless legs syndrome using prodrugs of gaba analogs
|
|
WO2005037784A2
(en)
*
|
2003-10-14 |
2005-04-28 |
Xenoport, Inc. |
Crystalline form of gamma-aminobutyric acid analog
|
|
ITMI20032165A1
(it)
*
|
2003-11-11 |
2005-05-12 |
Zambon Spa |
Processo di preparazione di gabapentina
|
|
CA2548917C
(en)
|
2003-12-11 |
2014-09-23 |
Sepracor Inc. |
Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
|
|
EP1737466A1
(en)
*
|
2004-01-29 |
2007-01-03 |
Pfizer Products Inc. |
COMBINATION OF y-AMINOBUTYRIC ACID MODULATORS AND 5-HT-1b RECEPTOR ANTAGONISTS
|
|
US20050187295A1
(en)
*
|
2004-02-19 |
2005-08-25 |
Surendra Kalyan |
Processes for the preparation of gabapentin
|
|
EP1763503A1
(en)
*
|
2004-03-17 |
2007-03-21 |
Hikal Limited |
4-t-butylgabapentin and its synthesis
|
|
ITMI20040579A1
(it)
*
|
2004-03-25 |
2004-06-25 |
Zambon Spa |
Processo di preparazione di gabapentina
|
|
WO2005102366A2
(en)
*
|
2004-04-19 |
2005-11-03 |
Philip Maxwell Satow |
Lithium combinations, and uses related thereto
|
|
BRPI0511941A
(pt)
*
|
2004-06-09 |
2008-01-22 |
Pfizer |
uso de (s, s)-reboxetina ou reboxetina racêmica
|
|
GB0416228D0
(en)
*
|
2004-07-20 |
2004-08-25 |
Sandoz Ind Products S A |
Process for the preparation of gabapentin
|
|
GB0419849D0
(en)
*
|
2004-09-07 |
2004-10-13 |
Pfizer Ltd |
Pharmaceutical combination
|
|
PT1809271E
(pt)
*
|
2004-09-10 |
2010-08-30 |
Newron Pharm Spa |
Utilização de (halogenobenziloxi)benzilamino-propanamidas para o fabrico de medicamentos activos como moduladores selectivos dos canais de sódio e/ou de cálcio
|
|
US8795725B2
(en)
|
2004-11-04 |
2014-08-05 |
Xenoport, Inc. |
GABA analog prodrug sustained release oral dosage forms
|
|
US7678363B2
(en)
|
2005-08-26 |
2010-03-16 |
Braincells Inc |
Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
|
|
EP2258358A3
(en)
|
2005-08-26 |
2011-09-07 |
Braincells, Inc. |
Neurogenesis with acetylcholinesterase inhibitor
|
|
US8378096B2
(en)
*
|
2005-09-23 |
2013-02-19 |
Janssen Pharmaceutica N.V. |
Hexahydro-cycloheptapyrazole cannabinoid modulators
|
|
US8378117B2
(en)
*
|
2005-09-23 |
2013-02-19 |
Janssen Pharmaceutica N.V. |
Hexahydro-cycloheptapyrazole cannabinoid modulators
|
|
EP1937646A1
(en)
*
|
2005-09-23 |
2008-07-02 |
Janssen Pharmaceutica N.V. |
Tetrahydro-cyclopentyl pyrazole cannabinoid modulators
|
|
RS51298B
(sr)
*
|
2005-09-23 |
2010-12-31 |
Janssen Pharmaceutica N.V. |
Modulatori heksahidro-ciklooktil pirazol kanabinoida
|
|
US7825151B2
(en)
*
|
2005-09-23 |
2010-11-02 |
Janssen Pharmaceutica Nv |
Hexahydro-cyclooctyl pyrazole cannabinoid modulators
|
|
DK1937259T3
(da)
*
|
2005-09-23 |
2012-02-13 |
Janssen Pharmaceutica Nv |
Hexahydro-cycloheptapyrazol-cannabinoid-modulatorer
|
|
EP1940389A2
(en)
|
2005-10-21 |
2008-07-09 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
|
US20070112017A1
(en)
*
|
2005-10-31 |
2007-05-17 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
US20070117858A1
(en)
*
|
2005-11-23 |
2007-05-24 |
Mingde Xia |
Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators
|
|
US20090176882A1
(en)
|
2008-12-09 |
2009-07-09 |
Depomed, Inc. |
Gastric retentive gabapentin dosage forms and methods for using same
|
|
US7526911B2
(en)
*
|
2006-02-03 |
2009-05-05 |
Rolls-Royce Corporation |
Gas turbine engine fuel system with fuel metering valve
|
|
EP1820502A1
(en)
|
2006-02-10 |
2007-08-22 |
Laboratorios Del Dr. Esteve, S.A. |
Active substance combination comprising azolylcarbinol compounds
|
|
WO2007095513A1
(en)
*
|
2006-02-14 |
2007-08-23 |
Janssen Pharmaceutica, Nv |
Tetrahydr0-2h-indaz0le derivatives for use as cannabinoid modulators
|
|
BRPI0708671A2
(pt)
*
|
2006-03-06 |
2011-06-07 |
Pfizer Prod Inc |
ligantes alfa-2-delta para sono não restaurador
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
WO2007112402A1
(en)
*
|
2006-03-27 |
2007-10-04 |
Janssen Pharmaceutica N.V. |
Tetrahydro-1h-1,2,6-triaza-azulene cannabinoid modulators
|
|
US20070254911A1
(en)
*
|
2006-03-27 |
2007-11-01 |
Mingde Xia |
Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators
|
|
MX2008014320A
(es)
|
2006-05-09 |
2009-03-25 |
Braincells Inc |
Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
|
|
AU2007249399A1
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
US7442834B2
(en)
*
|
2006-06-12 |
2008-10-28 |
Zhejiang Chiral Medicine Chemicals Co., Ltd. |
Process suitable for industrial scale production of gabapentin
|
|
CN101484413B
(zh)
*
|
2006-06-30 |
2014-05-14 |
Zach系统股份公司 |
制备加巴喷丁的方法
|
|
JP2010502722A
(ja)
|
2006-09-08 |
2010-01-28 |
ブレインセルス，インコーポレイティド |
４−アシルアミノピリジン誘導体を含む組み合わせ
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
CN101652133A
(zh)
*
|
2006-12-08 |
2010-02-17 |
克塞诺波特公司 |
Gaba类似物的前药用于治疗疾病的用途
|
|
WO2008077599A1
(en)
|
2006-12-22 |
2008-07-03 |
Recordati Ireland Limited |
COMBINATION THERAPY OF LOWER URINARY TRACT DISORDERS WITH α2δ LIGANDS AND NSAIDS
|
|
JP2010521453A
(ja)
*
|
2007-03-15 |
2010-06-24 |
サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド |
新規プロドラッグ
|
|
TW200908957A
(en)
*
|
2007-06-15 |
2009-03-01 |
Xenoport Inc |
Use of prodrugs of GABA analogs, antispasticity agents, and prodrugs of GABAB receptor agonists for treating spasticity
|
|
US7943653B2
(en)
*
|
2007-08-13 |
2011-05-17 |
Janssen Pharmaceutica N.V. |
Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators
|
|
US20090062392A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched gabapentin
|
|
TW200936123A
(en)
*
|
2007-11-06 |
2009-09-01 |
Xenoport Inc |
Use of prodrugs of GABAb agonists for treating neuropathic and musculoskeletal pain
|
|
TWI369202B
(en)
*
|
2008-01-25 |
2012-08-01 |
Xenoport Inc |
Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs
|
|
WO2009094563A2
(en)
|
2008-01-25 |
2009-07-30 |
Xenoport, Inc. |
Crystalline form of calcium-salts of (3s)-aminomethyl-b-methyl-hexanoic acids and methods of use
|
|
US7868043B2
(en)
|
2008-01-25 |
2011-01-11 |
Xenoport, Inc. |
Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
|
|
EP2116539A1
(en)
|
2008-04-25 |
2009-11-11 |
Laboratorios Del. Dr. Esteve, S.A. |
1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
|
|
US20100190752A1
(en)
*
|
2008-09-05 |
2010-07-29 |
Gruenenthal Gmbh |
Pharmaceutical Combination
|
|
EP2344447B1
(en)
|
2008-10-08 |
2016-06-08 |
Xgene Pharmaceutical Inc |
Gaba conjugates and methods of use thereof
|
|
US9192681B2
(en)
|
2009-02-24 |
2015-11-24 |
Nektar Therapeutics |
Oligomer-amino acid conjugates
|
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
US20110124705A1
(en)
*
|
2009-11-24 |
2011-05-26 |
Xenoport, Inc. |
Prodrugs of alpha-2-delta ligands, pharmaceutical compositions and uses thereof
|
|
US20110130454A1
(en)
*
|
2009-11-24 |
2011-06-02 |
Xenoport, Inc. |
Prodrugs of gamma-amino acid, alpha-2-delta ligands, pharmaceutical compositions and uses thereof
|
|
WO2011071995A2
(en)
|
2009-12-08 |
2011-06-16 |
Case Western Reserve University |
Compounds and methods of treating ocular disorders
|
|
EP2353591A1
(en)
|
2010-02-04 |
2011-08-10 |
Laboratorios Del. Dr. Esteve, S.A. |
Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
|
|
EP2368872A1
(en)
|
2010-03-25 |
2011-09-28 |
Serichim S.r.l. |
Process for the preparation of Gabapentin
|
|
EP2388005A1
(en)
|
2010-05-21 |
2011-11-23 |
Laboratorios Del. Dr. Esteve, S.A. |
Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
|
|
WO2011151708A1
(en)
|
2010-06-01 |
2011-12-08 |
Rubicon Research Private Limited |
Gastroretentive dosage forms of gaba analogs
|
|
US8431739B2
(en)
|
2010-06-14 |
2013-04-30 |
Divi's Laboratories, Ltd. |
Process for the preparation of gabapentin
|
|
WO2012015027A1
(ja)
|
2010-07-30 |
2012-02-02 |
東レ株式会社 |
神経障害性疼痛の治療剤又は予防剤
|
|
EP2415471A1
(en)
|
2010-08-03 |
2012-02-08 |
Laboratorios Del. Dr. Esteve, S.A. |
Use of sigma ligands in opioid-induced hyperalgesia
|
|
JP2013216580A
(ja)
*
|
2010-08-06 |
2013-10-24 |
Kyorin Pharmaceutical Co Ltd |
ビシクロ［２．２．２］オクチルアミン誘導体の製造方法
|
|
EP2524694A1
(en)
|
2011-05-19 |
2012-11-21 |
Laboratorios Del. Dr. Esteve, S.A. |
Use of sigma ligands in diabetes type-2 associated pain
|
|
EP2530072A1
(en)
|
2011-06-03 |
2012-12-05 |
Lacer, S.A. |
New compounds, synthesis and use thereof in the treatment of pain
|
|
US9066853B2
(en)
|
2013-01-15 |
2015-06-30 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable fiber
|
|
ITMI20131757A1
(it)
|
2013-10-22 |
2015-04-23 |
Zach System Spa |
Processo di preparazione di gabapentina
|
|
CA2928559C
(en)
|
2013-11-01 |
2022-08-30 |
Glytech, Inc. |
Method of manufacturing d- or l-form amino acid derivative possessing a thiol group
|
|
MA39146A1
(fr)
|
2013-12-17 |
2017-11-30 |
Esteve Labor Dr |
Combinaisons de gabapentanoïdes et de ligands des récepteurs sigma
|
|
TW201607538A
(zh)
|
2013-12-17 |
2016-03-01 |
以斯提夫博士實驗室股份有限公司 |
血清素－去甲腎上腺素再攝取抑制劑（ＳＮＲＩＳ）和σ受體配體組合物
|
|
EP2923694B1
(en)
|
2014-03-27 |
2018-11-14 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Oral liquid pharmaceutical solution of gabapentin
|
|
PT3554490T
(pt)
|
2016-12-16 |
2022-03-17 |
Idorsia Pharmaceuticals Ltd |
Combinação farmacêutica compreendendo um bloqueador de canais de cálcio de tipo t
|
|
EP3818981B1
(en)
|
2018-07-04 |
2024-02-21 |
Amézcua Amézcua, Federico |
Synergic pharmaceutical composition of the active enantiomer (s)-ketorolac and gabapentin for the treatment of neuropathic pain
|
|
US10399926B1
(en)
|
2018-08-01 |
2019-09-03 |
Divi's Laboratories Ltd. |
Process for the preparation of gabapentin
|
|
CN112839661A
(zh)
|
2018-10-11 |
2021-05-25 |
萨尼菲特治疗有限公司 |
用于治疗异位钙化的肌醇磷酸酯类
|
|
JPWO2021079887A1
(es)
|
2019-10-25 |
2021-04-29 |
|
|
|
EP4015494A1
(en)
|
2020-12-15 |
2022-06-22 |
Sanifit Therapeutics S.A. |
Processes for the preparation of soluble salts of inositol phosphates
|
|
GB2625579A
(en)
|
2022-12-21 |
2024-06-26 |
Novumgen Ltd |
An orally disintegrating tablet containing gabapentin or pharmaceutically acceptable salts thereof and the process of preparing the same
|